Your browser doesn't support javascript.
Modeling the viral dynamics of SARS-CoV-2 infection.
Wang, Sunpeng; Pan, Yang; Wang, Quanyi; Miao, Hongyu; Brown, Ashley N; Rong, Libin.
  • Wang S; Department of Biology, New York University, New York, NY 10012, United States of America.
  • Pan Y; Beijing Center for Disease Prevention and Control, Beijing 100013, China; Beijing Research Center for Preventive Medicine, Beijing, China; School of Public Health, Capital Medical University, Beijing, China.
  • Wang Q; Beijing Center for Disease Prevention and Control, Beijing 100013, China; Beijing Research Center for Preventive Medicine, Beijing, China.
  • Miao H; Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center at Houston, TX, 77030, United States of America.
  • Brown AN; Institute for Therapeutic Innovation, Department of Medicine, College of Medicine, University of Florida, Orlando, FL 32827, United States of America.
  • Rong L; Department of Mathematics, University of Florida, Gainesville, FL 32611, United States of America. Electronic address: libinrong@ufl.edu.
Math Biosci ; 328: 108438, 2020 10.
Article in English | MEDLINE | ID: covidwho-696903
ABSTRACT
Coronavirus disease 2019 (COVID-19), an infectious disease caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading and causing the global coronavirus pandemic. The viral dynamics of SARS-CoV-2 infection have not been quantitatively investigated. In this paper, we use mathematical models to study the pathogenic features of SARS-CoV-2 infection by examining the interaction between the virus, cells and immune responses. Models are fit to the data of SARS-CoV-2 infection in patients and non-human primates. Data fitting and numerical simulation show that viral dynamics of SARS-CoV-2 infection have a few distinct stages. In the initial stage, viral load increases rapidly and reaches the peak, followed by a plateau phase possibly generated by lymphocytes as a secondary target of infection. In the last stage, viral load declines due to the emergence of adaptive immune responses. When the initiation of seroconversion is late or slow, the model predicts viral rebound and prolonged viral persistence, consistent with the observation in non-human primates. Using the model we also evaluate the effect of several potential therapeutic interventions for SARS-CoV-2 infection. Model simulation shows that anti-inflammatory treatments or antiviral drugs combined with interferon are effective in reducing the duration of the viral plateau phase and diminishing the time to recovery. These results provide insights for understanding the infection dynamics and might help develop treatment strategies against COVID-19.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Models, Biological Type of study: Experimental Studies / Observational study / Prognostic study Limits: Animals / Humans Language: English Journal: Math Biosci Year: 2020 Document Type: Article Affiliation country: J.mbs.2020.108438

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Models, Biological Type of study: Experimental Studies / Observational study / Prognostic study Limits: Animals / Humans Language: English Journal: Math Biosci Year: 2020 Document Type: Article Affiliation country: J.mbs.2020.108438